596 related articles for article (PubMed ID: 10861056)
1. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
[TBL] [Abstract][Full Text] [Related]
2. Impact of Flt-3 ligand on donor-derived antigen presenting cells and alloimmune reactivity in heart graft recipients given adjuvant donor bone marrow.
Khanna A; Antonysamy MA; Subbotin VM; Steptoe RJ; Li W; Rudert WA; Thomson AW
Transpl Immunol; 1998 Dec; 6(4):225-34. PubMed ID: 10342736
[TBL] [Abstract][Full Text] [Related]
3. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients.
Antonysamy MA; Steptoe RJ; Khanna A; Rudert WA; Subbotin VM; Thomson AW
J Immunol; 1998 Apr; 160(8):4106-13. PubMed ID: 9558122
[TBL] [Abstract][Full Text] [Related]
4. Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus.
Iyengar AR; Bonham CA; Antonysamy MA; Subbotin VM; Khanna A; Murase N; Rao AS; Starzl TE; Thomson AW
Transplantation; 1997 May; 63(9):1193-9. PubMed ID: 9158008
[TBL] [Abstract][Full Text] [Related]
5. Promotion of skin graft tolerance across MHC barriers by mobilization of dendritic cells in donor hemopoietic cell infusions.
Eto M; Hackstein H; Kaneko K; Nomoto K; Thomson AW
J Immunol; 2002 Sep; 169(5):2390-6. PubMed ID: 12193706
[TBL] [Abstract][Full Text] [Related]
6. Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection.
Morelli AE; O'Connell PJ; Khanna A; Logar AJ; Lu L; Thomson AW
Transplantation; 2000 Jun; 69(12):2647-57. PubMed ID: 10910289
[TBL] [Abstract][Full Text] [Related]
7. Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow.
Khanna A; Steptoe RJ; Antonysamy MA; Li W; Thomson AW
Transplantation; 1998 Feb; 65(4):479-85. PubMed ID: 9500620
[TBL] [Abstract][Full Text] [Related]
8. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
9. Normal donor bone marrow is superior to Flt3 ligand-mobilized bone marrow in prolonging heart allograft survival when combined with anti-CD40L (CD154).
Hackstein H; Wang Z; Morelli AE; Kaneko K; Takayama T; Colvin BL; Bein G; Thomson AW
Am J Transplant; 2002 Aug; 2(7):609-17. PubMed ID: 12201361
[TBL] [Abstract][Full Text] [Related]
10. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.
Fu F; Li Y; Qian S; Lu L; Chambers F; Starzl TE; Fung JJ; Thomson AW
Transplantation; 1996 Sep; 62(5):659-65. PubMed ID: 8830833
[TBL] [Abstract][Full Text] [Related]
11. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes.
Lu L; McCaslin D; Starzl TE; Thomson AW
Transplantation; 1995 Dec; 60(12):1539-45. PubMed ID: 8545887
[TBL] [Abstract][Full Text] [Related]
13. Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance.
Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
J Immunol; 2001 May; 166(9):5619-28. PubMed ID: 11313402
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
15. Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time.
Wang Z; Castellaneta A; De Creus A; Shufesky WJ; Morelli AE; Thomson AW
J Immunol; 2004 May; 172(10):5924-30. PubMed ID: 15128773
[TBL] [Abstract][Full Text] [Related]
16. Trafficking of APC from liver allografts of Flt3L-treated donors: augmentation of potent allostimulatory cells in recipient lymphoid tissue is associated with a switch from tolerance to rejection.
Steptoe RJ; Li W; Fu F; O'Connell PJ; Thomson AW
Transpl Immunol; 1999 Mar; 7(1):51-7. PubMed ID: 10375078
[TBL] [Abstract][Full Text] [Related]
17. Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts.
O'Connell PJ; Li W; Wang Z; Specht SM; Logar AJ; Thomson AW
J Immunol; 2002 Jan; 168(1):143-54. PubMed ID: 11751957
[TBL] [Abstract][Full Text] [Related]
18. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival.
Takayama T; Kaneko K; Morelli AE; Li W; Tahara H; Thomson AW
Transplantation; 2002 Jul; 74(1):112-9. PubMed ID: 12134108
[TBL] [Abstract][Full Text] [Related]
19. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
[TBL] [Abstract][Full Text] [Related]
20. Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand.
Daro E; Pulendran B; Brasel K; Teepe M; Pettit D; Lynch DH; Vremec D; Robb L; Shortman K; McKenna HJ; Maliszewski CR; Maraskovsky E
J Immunol; 2000 Jul; 165(1):49-58. PubMed ID: 10861034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
